Irreversible multitargeted ErbB family inhibitors for therapy of lung and breast cancer.

Irreversible multitargeted ErbB family inhibitors for therapy of lung and breast cancer.

Item
http://www.wikidata.org/entity/Q38272862
Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset.EGFR regulates the development and microarchitecture of intratumoral angiogenic vasculature capable of sustaining cancer cell intravasation.Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design.Identification of critical paralog groups with indispensable roles in the regulation of signaling flow.Network analysis of mitonuclear GWAS reveals functional networks and tissue expression profiles of disease-associated genes.Molecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer.Perspectives of HER2-targeting in gastric and esophageal cancer.Determining EGFR-TKI sensitivity of G719X and other uncommon EGFR mutations in non-small cell lung cancer: Perplexity and solution (Review).An overview of quinoline as a privileged scaffold in cancer drug discovery.Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations.HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody in vivo.Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.The irreversible ERBB1/2/4 inhibitor neratinib interacts with the BCL-2 inhibitor venetoclax to kill mammary cancer cells.Effects of neratinib and combination with irradiation and chemotherapy in head and neck cancer cells.
P2860

Irreversible multitargeted ErbB family inhibitors for therapy of lung and breast cancer.

Item
http://www.wikidata.org/entity/Q38272862
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Irreversible multitargeted ErbB family inhibitors for therapy of lung and breast cancer.
@en
type
label
Irreversible multitargeted ErbB family inhibitors for therapy of lung and breast cancer.
@en
prefLabel
Irreversible multitargeted ErbB family inhibitors for therapy of lung and breast cancer.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Irreversible multitargeted ErbB family inhibitors for therapy of lung and breast cancer.
@en
P2093
P304
P31
P356
10.2174/1568009614666141111104643
P433
P478
P577
P698